Eltrombopag in chronic idiopathic thrombocytopenic purpura

Lancet. 2009 Feb 21;373(9664):607-8. doi: 10.1016/S0140-6736(09)60377-9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Benzoates / adverse effects
  • Benzoates / therapeutic use*
  • Chronic Disease
  • Double-Blind Method
  • Hemorrhage / etiology
  • Humans
  • Hydrazines / adverse effects
  • Hydrazines / therapeutic use*
  • Multicenter Studies as Topic
  • Platelet Count
  • Purpura, Thrombocytopenic, Idiopathic / blood
  • Purpura, Thrombocytopenic, Idiopathic / complications
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use*
  • Quality of Life
  • Randomized Controlled Trials as Topic

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • eltrombopag